Antifection

Items 301-350 of 393

per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. antibacterial candidate for clinical trials

    Zabofloxacin (DW-224a Free base) is a novel fluoronaphthyridone quinolone with a 7-pyrrolidone substituent that is considered a potent antibacterial candidate for clinical trials.
  2. anti-tuberculosis agent

    TBAJ-587, a potent anti-tuberculosis agent, inhibits M.tb strain H37Rv growth with MIC90s of 0.006 and <0.02 ?g/mL in MABA and LORA assay, respectively.
  3. Fosmidomycin sodium salt is a phosphonic acid antibiotic and a antimalarial drug, which is active against both Gram-negative and Gram-positive bacteria.
  4. MF 5137 is a potent antibacterial agent.
  5. Nucleocidin is an antitrypanosomal antibiotic, inhibiting the transfer of labeled amino acid from S-RNA to protein.
  6. Dihydrofolate inhibitor

    Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL.
  7. RMI 10874 is a tilorone analogue. Tilorone is a small-molecule, orally bioavailable antiviral agent. RMI 10874 completely abolishes lung colonization of an H-2 negative (GR9.B9) MCA-induced fibrosarcoma clone.
  8. DNA gyrase inhibitor

    Closthioamide is a potent inhibitor of bacterial DNA gyrase and highly active against Ec, MRSA, VRE and Mv), with MICs of 9.00 μM, 0.58 μM, 0.58 μM and 72.03 μM respectively.
  9. Xenalamine is a synthetic antiviral agent.
  10. antifungal drug

    Chlordantoin is an antifungal drug which can be used to treat vaginal candidiasis.
  11. Sulfasymazine is a sulfonamide drug and displays antibacterial properties.
  12. broad-spectrum arenavirus inhibitor

    ST-193 is a potent broad-spectrum arenavirus inhibitor; inhibits Guanarito, Junin, Lassa and Machupo virus with IC50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively.
  13. oxazolidinone antibiotic

    Cadazolid (ACT-179811) is a new oxazolidinone antibiotic with potent activity against Clostridium difficile.
  14. Oxaquin (MCB-3837) is a water-soluble, injectable prodrug that is rapidly converted to the active sub-stance MCB3681 in vivo following intravenous (i.v.) administration, active against Gram-positive bacterial species. Oxaquin (MCB-3837) itself has no antimicrobial effects.
  15. antimicrobial compound

    Antibiotic-5d is a synthesis and antimicrobial compound.
  16. Bicyclomycin benzoate is an antibiotic exhibiting activity against a broad spectrum of Gram-negative bacteria and against the Gram-positive bacterium.
  17. Monobehenin has a strong inhibitory activity toward bacterial biofilm formation.
  18. RLR agonist

    KIN1408 is an antiviral small molecule compound, as agonists of the RLR pathway.
  19. LpxC inhibitor

    ACHN-975 is a selective LpxC inhibitor, exhibiting a subnanomolar LpxC inhibitory activity and low MIC values (≤1 μg/mL) against a wide range of Gram-negative bacteria.

  20. Brilacidin is a nonpeptidic anti-infective in a new class of defensin mimetics that is being developed for the treatment of eye infections.
  21. antibacterial agent

    BMY-43748 is a promising antibacterial agent, exhibiting great in vitro and in vivo antibacterial activity.
  22. KB-5246 is a tetracyclic quinolone and displays antibacterial activities.
  23. Ribocil is a highly selective chemical modulator of bacterial riboflavin riboswitches. Ribocil strongly inhibits GFP expression, achieving a 50% effective concentration (EC50) of 0.3 μM.
  24. N-Acetyl-Calicheamicin is a potent enediyne antitumor antibiotic.
  25. UL97 kinase inhibitor

    Maribavir is an UL97 kinase inhibitor potentially for the treatment of cytomegalovirus (CMV) infection. The mechanism by which maribavir inhibits HCMV replication is by inhibition of an HCMV encoded protein kinase enzyme called UL97 or pUL97.
  26. CYP51 inhibitor

    Oteseconazole (VT-1161) is an orally active anti-fungal agent, potently binds to and inhibits Candida albicans CYP51 (Kd, <39 nM), shows no obvious effect on human CYP51.
  27. Cefiderocol (S-649266) is a novel siderophore cephalosporin which has a potent activity against a broad range of aerobic Gram-negative bacterial species with MIC50s of 2 μg/mL or less.
  28. Hetacillin potassium is a broad-spectrum treatment for use against a wide range of common Gram-positive and Gram-negative bacteria.
  29. AVX 13616 shows the potent in vivo antibacterial activity of Avexa??s lead antibacterial candidate; particularly against drug-resistant Staphylococcus pathogens.
  30. Piperazine Citrate is an organic compound that consists of a six-membered ring, containting two nitrogen atoms at opposite positions in the ring; first introduced in 1953 as an Anthelmintic.
  31. Fabl inhibitor

    AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ??0.12 μg/ml.
  32. Heparin is a highly sulfated glycosaminoglycan,that is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule.
  33. Tubulysin A(TubA) is a myxobacterial product that can function as an antiangiogenic agent in many in vitro assays; anti-microtubule, anti-mitotic, an apoptosis inducer, anticancer, anti-angiogenic, and antiproliferative.
  34. G-418 (disulfate) is an aminoglycoside antibiotic similar in structure to gentamicin B1, which blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.
  35. Apramycin(Nebramycin II) is an aminoglycoside antibiotic used in veterinary medicine.
  36. Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and skin-structure infections and community-acquired pneumonia.
  37. Methasulfocarb is a fungicide compound.
  38. Ridinilazole is a novel antibacterial with MICs range of 0.06-0.25??g/mL (MIC90=8??g/mL) against C.?difficile.
  39. diazabicyclooctane inhibitor

    Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes.
  40. Squalamine lactate is an aminosterol compound discovered in the tissues of the dogfish shark, with antimicrobial activity, and used for the treatment of neovascular age-related macular degeneration.
  41. Bethoxazin(Bethoguard) is a new broad spectrum industrial microbicide with applications in material and coating preservation.
  42. FabI enzyme inhibitor

    MUT056399 (Fab-001) is a highly potent inhibitor of the FabI enzyme of both S. aureus and E. coli with 50% inhibitory concentration IC50s of 12 nM and 58 nM, respectively.
  43. Meptyldinocap (2,4-DNOPC) is a novel powdery mildew (Erysiphe necator) fungicide which shows protectant and post-infective activities.
  44. Flumorph(SYP-L190) is a carboxylic acid amide (CAA) fungicide.
  45. Penthiopyrad(MTF-753) is a carboxamide fungicide used to control a broad spectrum of diseases on large variety of corps; inhibits fungal respiration by binding to mitochondrial respiratory complex II.
  46. Valifenalate(IR5885; Valiphenal), which is approved for application on high-value crops such as grapes, tomatoes and other vegetables, is effective against various types of mildew and is currently marketed primarily under the Valis moniker; insecticide agent.
  47. Tiadinil is a plant activator of systemic acquired resistance, boosts the production of herbivore-induced plant volatiles; fungicide.
  48. Tolfenpyrad is a pesticide that was first approved in 2002 in Japan.
  49. Tulathromycin A is a macrolide antibiotic.
  50. protein kinase G (PknG) inhibitor

    AX20017 is a small-molecule protein kinase G (PknG) inhibitor with an IC50 of 0.39 μM.

Items 301-350 of 393

per page
Set Descending Direction